AU4559400A - Controlled release pharmaceutical preparation containing metamizole - Google Patents

Controlled release pharmaceutical preparation containing metamizole

Info

Publication number
AU4559400A
AU4559400A AU45594/00A AU4559400A AU4559400A AU 4559400 A AU4559400 A AU 4559400A AU 45594/00 A AU45594/00 A AU 45594/00A AU 4559400 A AU4559400 A AU 4559400A AU 4559400 A AU4559400 A AU 4559400A
Authority
AU
Australia
Prior art keywords
controlled release
pharmaceutical preparation
preparation containing
release pharmaceutical
metamizole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45594/00A
Inventor
Brigitte Freudensprung
Karin Klokkers
Thomas Strungmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU4559400A publication Critical patent/AU4559400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU45594/00A 1999-05-04 2000-04-28 Controlled release pharmaceutical preparation containing metamizole Abandoned AU4559400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19920415 1999-05-04
DE1999120415 DE19920415A1 (en) 1999-05-04 1999-05-04 Controlled-release pharmaceutical composition containing metamizole
PCT/EP2000/003885 WO2000066088A1 (en) 1999-05-04 2000-04-28 Controlled release pharmaceutical preparation containing metamizole

Publications (1)

Publication Number Publication Date
AU4559400A true AU4559400A (en) 2000-11-17

Family

ID=7906884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45594/00A Abandoned AU4559400A (en) 1999-05-04 2000-04-28 Controlled release pharmaceutical preparation containing metamizole

Country Status (3)

Country Link
AU (1) AU4559400A (en)
DE (1) DE19920415A1 (en)
WO (1) WO2000066088A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008022520A1 (en) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Solid sustained-release pharmaceutical formulation
CN103610656B (en) * 2013-12-05 2016-02-03 昆明振华制药厂有限公司 A kind of preparation method of analgin tablet
EP3265097A4 (en) 2015-03-03 2018-11-07 Kindred Biosciences Inc. Compositions and methods for treatment and prevention of pyrexia in horses
WO2018087109A1 (en) 2016-11-08 2018-05-17 Grünenthal GmbH Multiparticulate dosage form with controlled release of metamizol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0196119A (en) * 1987-10-08 1989-04-14 Nitto Denko Corp Temperature-sensitive slowly diffusing material
JPH0816051B2 (en) * 1988-12-07 1996-02-21 エスエス製薬株式会社 Sustained release suppositories
JPH06100602A (en) * 1992-09-18 1994-04-12 Asahi Chem Ind Co Ltd Solid oral preparation and production thereof
EP0898961A1 (en) * 1997-08-27 1999-03-03 Herta-Maria Dr. Sahlender Pharmaceutical composition to improve the therapy of acute, postoperative or chronic pain
IT1303693B1 (en) * 1998-11-03 2001-02-23 Formenti Farmaceutici Spa METAMIZOLE CONTROLLED RELEASE COMPOSITIONS.

Also Published As

Publication number Publication date
WO2000066088A1 (en) 2000-11-09
DE19920415A1 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
AU5914999A (en) Controlled release drug delivery
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU1071301A (en) Pharmaceutical compounds
AU5335698A (en) Pharmaceutical formulations with delayed drug release
AU7641300A (en) Release system
AU2791599A (en) Extended release dosage form
CZ20011186A3 (en) Stabilized pharmaceutical preparation
HUP0301242A3 (en) Controlled release drug dosage form
AU2001286677A1 (en) Controlled release of substances
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU3192700A (en) Medicinal compositions
AU2001283359A1 (en) Drug release (delivery system)
AU7578598A (en) Controlled release dosage forms containing water soluble drugs
AU1887401A (en) Medicinal composition
AU2005300A (en) Medicinal compositions
AU4328800A (en) Pharmaceutical formulation
AU6715600A (en) Pharmaceutical formulations
AU4213299A (en) Controlled release of substances
AU2001232948A1 (en) Controlled release of drugs
AU5820900A (en) Capsule for the controlled release of active substances
HK1046140A1 (en) Solid pharmaceutical preparation
AU7937500A (en) Pharmaceutical composition containing midazolam
AU4977300A (en) Pharmaceutical formulations
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU1385801A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase